RecallRadar

FDA Drug recall D-0848-2026

Lidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, L6T1C, Canada, Dist…

On 2026-09-23 the FDA classified a Class II recall of Lidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, L6T1C, Canada, Dist… by Sun Pharma Taro, citing failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0848-2026
ClassificationClass II
Statusongoing
Initiated2026-08-31
Published2026-09-23
Last updated2026-09-29 05:30 UTC
CompanySun Pharma Taro
DistributionUS

Product

Lidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, L6T1C, Canada, Dist By: Taro Pharmaceuticals U.S.A. Inc. Hawthorne NY 70532 NDC: 51672-3008-5

Reason

Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).

Identifiers

ndc51672-3008-5
ndc51672-3008-3
code_infoLot # AD48154, Exp: 4/30/2027.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-29 05:30 UTC. Current status: ongoing.

Other recalls by Sun Pharma Taro

All Sun Pharma Taro recalls

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0848-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.